Literature DB >> 16149079

Advances in understanding bone cancer pain.

M J Goblirsch1, P Zwolak, D R Clohisy.   

Abstract

Experimental animal models of bone cancer pain have emerged and findings have provided a unique glimpse into unraveling the mechanism that drives this debilitating condition. Key contributors to the generation and maintenance of bone cancer pain are tumor-induced osteolysis, tumor itself, and production of nociceptive mediators in the bone-tumor microenvironment. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh：

Year:  2005        PMID： 16149079     DOI： 10.1002/jcb.20589

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN： 0730-2312            Impact factor:   4.429


  21 in total

Review 1.  Palliative radiation therapy for canine osteosarcoma.

Authors:  Monique N Mayer; Candace K Grier
Journal:  Can Vet J       Date:  2006-07       Impact factor: 1.008

2.  Involvement of protease-activated receptor 2 in nociceptive behavior in a rat model of bone cancer.

Authors:  Yanju Bao; Baojin Hua; Wei Hou; Zhan Shi; Weidong Li; Conghuang Li; Cihui Chen; Rui Liu; Yinggang Qin
Journal:  J Mol Neurosci       Date:  2013-09-22       Impact factor: 3.444

3.  Characterization of Cancer-Induced Nociception in a Murine Model of Breast Carcinoma.

Authors:  Amanda Spring de Almeida; Flávia Karine Rigo; Samira Dal-Toé De Prá; Alessandra Marcone Milioli; Diéssica Padilha Dalenogare; Gabriele Cheiran Pereira; Camila Dos Santos Ritter; Diulle Spat Peres; Caren Tatiane de David Antoniazzi; Carolina Stein; Rafael Noal Moresco; Sara Marchesan Oliveira; Gabriela Trevisan
Journal:  Cell Mol Neurobiol       Date:  2019-03-08       Impact factor: 5.046

4.  Combined application of diclofenac and celecoxib with an opioid yields superior efficacy in metastatic bone cancer pain: a randomized controlled trial.

Authors:  Zunyong Liu; Yan Xu; Zhong-Liang Liu; Yi-Zhou Tian; Xiao-Heng Shen
Journal:  Int J Clin Oncol       Date:  2017-05-08       Impact factor: 3.402

5.  A novel approach to the use of animals in studies of pain: validation of the canine brief pain inventory in canine bone cancer.

Authors:  Dorothy Cimino Brown; Raymond Boston; James C Coyne; John T Farrar
Journal:  Pain Med       Date:  2008-09-24       Impact factor: 3.750

Review 6.  Animal models of cancer pain.

Authors:  Cholawat Pacharinsak; Alvin Beitz
Journal:  Comp Med       Date:  2008-06       Impact factor: 0.982

7.  Protein kinase C-beta inhibitor enzastaurin (LY317615.HCI) enhances radiation control of murine breast cancer in an orthotopic model of bone metastasis.

Authors:  Arkadiusz Z Dudek; Pawel Zwolak; Piotr Jasinski; Kaoru Terai; Nathan J Gallus; Marna E Ericson; Faris Farassati
Journal:  Invest New Drugs       Date:  2007-09-06       Impact factor: 3.850

8.  A Novel Mechanism of BAM8-22 Inhibiting Microglia Activation: Represses CX3CR1 Expression via Upregulating miR-184.

Authors:  Aitao Wang; Muer Tie; Dongmei Guo; Na Wu; Shanglong Yao; Limei Yan; Xingsheng Zhao
Journal:  J Mol Neurosci       Date:  2019-12-12       Impact factor: 3.444

9.  Enhanced excitability of small dorsal root ganglion neurons in rats with bone cancer pain.

Authors:  Qin Zheng; Dong Fang; Jie Cai; You Wan; Ji-Sheng Han; Guo-Gang Xing
Journal:  Mol Pain       Date:  2012-04-03       Impact factor: 3.395

10.  Lipoxins and aspirin-triggered lipoxin alleviate bone cancer pain in association with suppressing expression of spinal proinflammatory cytokines.

Authors:  Shan Hu; Qi-Liang Mao-Ying; Jun Wang; Zhi-Fu Wang; Wen-Li Mi; Xiao-Wei Wang; Jian-Wei Jiang; Ya-Lin Huang; Gen-Cheng Wu; Yan-Qing Wang
Journal:  J Neuroinflammation       Date:  2012-12-26       Impact factor: 8.322
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.